Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Composition | 29 | 2024 | 477 | 2.760 |
Why?
|
| Absorptiometry, Photon | 24 | 2022 | 170 | 1.810 |
Why?
|
| Adipose Tissue | 14 | 2020 | 446 | 1.360 |
Why?
|
| Whole-Body Counting | 4 | 2017 | 6 | 1.170 |
Why?
|
| Bone Density | 22 | 2022 | 307 | 1.160 |
Why?
|
| Phantoms, Imaging | 6 | 2013 | 126 | 1.140 |
Why?
|
| Bone and Bones | 10 | 2022 | 261 | 0.710 |
Why?
|
| Radiation Monitoring | 1 | 2017 | 13 | 0.580 |
Why?
|
| Thallium | 1 | 2017 | 9 | 0.580 |
Why?
|
| Iodides | 1 | 2017 | 13 | 0.570 |
Why?
|
| Sodium | 4 | 2017 | 290 | 0.550 |
Why?
|
| Monte Carlo Method | 2 | 2017 | 89 | 0.500 |
Why?
|
| Renal Dialysis | 2 | 2018 | 841 | 0.460 |
Why?
|
| Whole Body Imaging | 1 | 2013 | 28 | 0.440 |
Why?
|
| Models, Anatomic | 1 | 2013 | 96 | 0.410 |
Why?
|
| Pediatric Obesity | 4 | 2022 | 366 | 0.400 |
Why?
|
| Body Mass Index | 7 | 2024 | 1463 | 0.380 |
Why?
|
| Body Weight | 11 | 2017 | 963 | 0.370 |
Why?
|
| Calibration | 4 | 2022 | 82 | 0.320 |
Why?
|
| Child | 30 | 2024 | 24063 | 0.310 |
Why?
|
| Obesity | 8 | 2019 | 2083 | 0.290 |
Why?
|
| Weight Gain | 4 | 2019 | 382 | 0.290 |
Why?
|
| Pregnancy, Twin | 2 | 2018 | 168 | 0.290 |
Why?
|
| Breast Feeding | 2 | 2020 | 215 | 0.280 |
Why?
|
| beta-Glucans | 3 | 2013 | 20 | 0.280 |
Why?
|
| Insulin Resistance | 3 | 2022 | 631 | 0.280 |
Why?
|
| Isoflavones | 3 | 2013 | 44 | 0.280 |
Why?
|
| Adolescent | 23 | 2024 | 18940 | 0.270 |
Why?
|
| Infant, Premature | 5 | 2020 | 799 | 0.270 |
Why?
|
| Energy Metabolism | 4 | 2024 | 747 | 0.270 |
Why?
|
| Milk, Human | 2 | 2020 | 295 | 0.260 |
Why?
|
| Fetal Development | 2 | 2018 | 110 | 0.250 |
Why?
|
| Child, Preschool | 18 | 2024 | 13777 | 0.250 |
Why?
|
| Anthropometry | 5 | 2018 | 189 | 0.240 |
Why?
|
| Software | 3 | 2008 | 670 | 0.230 |
Why?
|
| Humans | 54 | 2024 | 122293 | 0.230 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 215 | 0.220 |
Why?
|
| Adiposity | 3 | 2022 | 181 | 0.210 |
Why?
|
| Cardiorespiratory Fitness | 1 | 2022 | 10 | 0.210 |
Why?
|
| Female | 37 | 2024 | 64882 | 0.210 |
Why?
|
| Potassium | 7 | 2015 | 279 | 0.210 |
Why?
|
| Osteoporosis | 2 | 2019 | 114 | 0.200 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 33 | 0.200 |
Why?
|
| Male | 32 | 2024 | 59520 | 0.190 |
Why?
|
| Body Height | 4 | 2018 | 205 | 0.190 |
Why?
|
| Dietary Supplements | 4 | 2018 | 460 | 0.180 |
Why?
|
| Osteosclerosis | 1 | 2020 | 12 | 0.180 |
Why?
|
| Reproducibility of Results | 9 | 2008 | 2796 | 0.180 |
Why?
|
| Exercise | 3 | 2021 | 790 | 0.170 |
Why?
|
| Reference Values | 7 | 2018 | 698 | 0.170 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2022 | 147 | 0.170 |
Why?
|
| Birth Weight | 2 | 2018 | 334 | 0.170 |
Why?
|
| Dwarfism | 1 | 2020 | 98 | 0.170 |
Why?
|
| Postmenopause | 2 | 2010 | 124 | 0.170 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 105 | 0.170 |
Why?
|
| Calcium | 7 | 2009 | 1095 | 0.160 |
Why?
|
| Infant | 11 | 2020 | 12302 | 0.160 |
Why?
|
| Young Adult | 5 | 2024 | 8760 | 0.160 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 38 | 0.160 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 66 | 0.160 |
Why?
|
| Age Factors | 7 | 2011 | 2777 | 0.160 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 62 | 0.160 |
Why?
|
| Skeleton | 1 | 1998 | 5 | 0.160 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 240 | 0.160 |
Why?
|
| Minerals | 1 | 1998 | 54 | 0.160 |
Why?
|
| Body Water | 5 | 2018 | 88 | 0.150 |
Why?
|
| Urogenital Abnormalities | 1 | 2020 | 163 | 0.150 |
Why?
|
| Overweight | 2 | 2024 | 343 | 0.150 |
Why?
|
| Models, Biological | 5 | 2007 | 1438 | 0.150 |
Why?
|
| Child Development | 1 | 2020 | 249 | 0.150 |
Why?
|
| Scintillation Counting | 1 | 2017 | 6 | 0.140 |
Why?
|
| Adult | 19 | 2022 | 28732 | 0.140 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2017 | 191 | 0.140 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 3301 | 0.140 |
Why?
|
| Rothmund-Thomson Syndrome | 1 | 2017 | 48 | 0.140 |
Why?
|
| Equipment Failure Analysis | 1 | 2017 | 89 | 0.140 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 738 | 0.140 |
Why?
|
| Nutritional Status | 1 | 2018 | 297 | 0.140 |
Why?
|
| Infant, Newborn | 10 | 2020 | 8096 | 0.140 |
Why?
|
| Infant Formula | 1 | 2017 | 98 | 0.130 |
Why?
|
| Proteins | 2 | 2018 | 1043 | 0.130 |
Why?
|
| Energy Intake | 1 | 2018 | 450 | 0.130 |
Why?
|
| Basal Metabolism | 3 | 2024 | 89 | 0.130 |
Why?
|
| Fractures, Bone | 1 | 2017 | 180 | 0.120 |
Why?
|
| Diet | 3 | 2020 | 1106 | 0.120 |
Why?
|
| Equipment Design | 1 | 2017 | 596 | 0.120 |
Why?
|
| Regression Analysis | 4 | 2008 | 755 | 0.120 |
Why?
|
| Swine | 6 | 2019 | 1157 | 0.120 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2015 | 49 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2017 | 606 | 0.120 |
Why?
|
| Hypertension | 1 | 2022 | 1274 | 0.110 |
Why?
|
| Polyvinyl Chloride | 1 | 2013 | 1 | 0.110 |
Why?
|
| Polyethylene | 1 | 2013 | 16 | 0.110 |
Why?
|
| Nylons | 1 | 2013 | 12 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 621 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 265 | 0.110 |
Why?
|
| Quality of Life | 2 | 2013 | 1913 | 0.110 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 114 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1283 | 0.110 |
Why?
|
| Camping | 1 | 2013 | 15 | 0.110 |
Why?
|
| Weight Loss | 2 | 2015 | 443 | 0.110 |
Why?
|
| Menopause | 1 | 2013 | 73 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 181 | 0.100 |
Why?
|
| Weight Reduction Programs | 1 | 2013 | 52 | 0.100 |
Why?
|
| Self Concept | 1 | 2013 | 156 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 323 | 0.100 |
Why?
|
| Growth and Development | 1 | 2011 | 22 | 0.090 |
Why?
|
| Phytoestrogens | 1 | 2010 | 16 | 0.090 |
Why?
|
| Blood Urea Nitrogen | 1 | 2010 | 70 | 0.090 |
Why?
|
| Neutron Activation Analysis | 4 | 1999 | 7 | 0.090 |
Why?
|
| Cohort Studies | 5 | 2024 | 4643 | 0.090 |
Why?
|
| Marfan Syndrome | 1 | 2012 | 136 | 0.090 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2009 | 12 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2010 | 117 | 0.080 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 192 | 0.080 |
Why?
|
| Growth Hormone | 1 | 2009 | 151 | 0.080 |
Why?
|
| Plasmids | 1 | 2009 | 516 | 0.080 |
Why?
|
| Body Fluid Compartments | 2 | 2018 | 18 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 2010 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 861 | 0.070 |
Why?
|
| Risk Factors | 4 | 2022 | 9902 | 0.070 |
Why?
|
| Plethysmography | 1 | 2007 | 34 | 0.070 |
Why?
|
| Placebos | 4 | 2013 | 239 | 0.070 |
Why?
|
| Potassium Radioisotopes | 3 | 2015 | 6 | 0.070 |
Why?
|
| Sex Factors | 2 | 2008 | 1238 | 0.070 |
Why?
|
| Vitamin D | 3 | 2018 | 157 | 0.070 |
Why?
|
| Body Constitution | 2 | 1998 | 31 | 0.070 |
Why?
|
| Gestational Age | 3 | 2018 | 1115 | 0.060 |
Why?
|
| Lumbar Vertebrae | 2 | 2022 | 107 | 0.060 |
Why?
|
| Pregnancy | 4 | 2019 | 7092 | 0.060 |
Why?
|
| Software Validation | 1 | 2004 | 11 | 0.060 |
Why?
|
| Calorimetry, Indirect | 1 | 2024 | 58 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2019 | 5963 | 0.060 |
Why?
|
| Middle Aged | 8 | 2020 | 25639 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2005 | 72 | 0.060 |
Why?
|
| Femur | 2 | 2020 | 58 | 0.060 |
Why?
|
| Indicator Dilution Techniques | 1 | 2022 | 23 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 1822 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 1993 | 259 | 0.050 |
Why?
|
| Deuterium | 1 | 2022 | 103 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2022 | 105 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 805 | 0.050 |
Why?
|
| Wnt-5a Protein | 1 | 2020 | 22 | 0.050 |
Why?
|
| Soybean Proteins | 1 | 2000 | 17 | 0.040 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 43 | 0.040 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2020 | 36 | 0.040 |
Why?
|
| Glypicans | 1 | 2020 | 39 | 0.040 |
Why?
|
| Arthritis, Juvenile | 1 | 2000 | 37 | 0.040 |
Why?
|
| Linear Models | 1 | 2001 | 657 | 0.040 |
Why?
|
| Olive Oil | 1 | 2019 | 22 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 458 | 0.040 |
Why?
|
| Emulsions | 1 | 2019 | 64 | 0.040 |
Why?
|
| Soybean Oil | 1 | 2019 | 65 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2001 | 381 | 0.040 |
Why?
|
| Aftercare | 1 | 2020 | 145 | 0.040 |
Why?
|
| Fish Oils | 1 | 2019 | 82 | 0.040 |
Why?
|
| Dietary Proteins | 1 | 2000 | 239 | 0.040 |
Why?
|
| Living Donors | 1 | 2019 | 111 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2013 | 1568 | 0.040 |
Why?
|
| Animals | 8 | 2019 | 33721 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2000 | 315 | 0.040 |
Why?
|
| Thinness | 1 | 1998 | 68 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 2018 | 173 | 0.040 |
Why?
|
| Medroxyprogesterone | 1 | 1997 | 8 | 0.040 |
Why?
|
| Amenorrhea | 1 | 1997 | 19 | 0.040 |
Why?
|
| Contraceptives, Oral | 1 | 1997 | 39 | 0.040 |
Why?
|
| RecQ Helicases | 1 | 2017 | 62 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2018 | 206 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 2017 | 54 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2022 | 1314 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 311 | 0.040 |
Why?
|
| Texas | 4 | 2015 | 3528 | 0.030 |
Why?
|
| Models, Structural | 2 | 1994 | 49 | 0.030 |
Why?
|
| Lactation | 1 | 2018 | 185 | 0.030 |
Why?
|
| Hypothalamic Diseases | 1 | 1997 | 37 | 0.030 |
Why?
|
| Triglycerides | 1 | 2019 | 560 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2017 | 154 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 2371 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 487 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1362 | 0.030 |
Why?
|
| Wasting Syndrome | 1 | 2015 | 26 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 346 | 0.030 |
Why?
|
| Peptide YY | 1 | 2015 | 17 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 592 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 46 | 0.030 |
Why?
|
| Analysis of Variance | 3 | 2005 | 1004 | 0.030 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 437 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 2015 | 21 | 0.030 |
Why?
|
| Adipokines | 1 | 2015 | 58 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2020 | 1462 | 0.030 |
Why?
|
| Leptin | 1 | 2015 | 209 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1034 | 0.030 |
Why?
|
| Time Factors | 4 | 2009 | 6182 | 0.030 |
Why?
|
| Elements | 1 | 1993 | 1 | 0.030 |
Why?
|
| Gamma Rays | 1 | 1993 | 49 | 0.030 |
Why?
|
| Fibrillins | 1 | 2012 | 31 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2019 | 12044 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2004 | 2080 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2030 | 0.030 |
Why?
|
| Pediatrics | 2 | 2018 | 1140 | 0.030 |
Why?
|
| Fibrillin-1 | 1 | 2012 | 57 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1993 | 382 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1993 | 164 | 0.020 |
Why?
|
| Seasons | 1 | 2013 | 300 | 0.020 |
Why?
|
| Hypocotyl | 1 | 2010 | 5 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2015 | 745 | 0.020 |
Why?
|
| United States | 2 | 2022 | 10487 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2013 | 445 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 276 | 0.020 |
Why?
|
| Endometrium | 1 | 2013 | 274 | 0.020 |
Why?
|
| Insulin | 1 | 2015 | 1191 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 55 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 923 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2009 | 184 | 0.020 |
Why?
|
| Europe | 2 | 2000 | 369 | 0.020 |
Why?
|
| Mexican Americans | 2 | 2000 | 197 | 0.020 |
Why?
|
| Sex Characteristics | 2 | 2000 | 308 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 941 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 340 | 0.020 |
Why?
|
| Eating | 1 | 2009 | 355 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 2937 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 2933 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1679 | 0.020 |
Why?
|
| Inulin | 1 | 2005 | 18 | 0.020 |
Why?
|
| Fructans | 1 | 2005 | 10 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2005 | 41 | 0.020 |
Why?
|
| Immunoassay | 1 | 2005 | 127 | 0.010 |
Why?
|
| Femur Neck | 1 | 2004 | 9 | 0.010 |
Why?
|
| Chlorine | 2 | 1994 | 14 | 0.010 |
Why?
|
| Polysaccharides | 1 | 2005 | 142 | 0.010 |
Why?
|
| Hip Joint | 1 | 2004 | 36 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 5734 | 0.010 |
Why?
|
| Spine | 1 | 2004 | 145 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 3626 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1315 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 465 | 0.010 |
Why?
|
| Dermatomyositis | 1 | 2001 | 20 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 17546 | 0.010 |
Why?
|
| Animal Feed | 1 | 2000 | 76 | 0.010 |
Why?
|
| Electric Impedance | 1 | 1999 | 56 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1999 | 89 | 0.010 |
Why?
|
| New York | 1 | 1999 | 66 | 0.010 |
Why?
|
| Growth | 1 | 1999 | 107 | 0.010 |
Why?
|
| Random Allocation | 1 | 1999 | 417 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 2525 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2001 | 261 | 0.010 |
Why?
|
| Rett Syndrome | 1 | 2001 | 281 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 1575 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2001 | 384 | 0.010 |
Why?
|
| Phosphorus | 1 | 1994 | 55 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1997 | 464 | 0.010 |
Why?
|
| Cadaver | 1 | 1993 | 132 | 0.010 |
Why?
|
| HIV Infections | 1 | 2001 | 1858 | 0.010 |
Why?
|